
City’s biotechs star in KPMG’s East of England study
Standout raises from Cambridge-based biotechnology companies Maxion Therapeutics (£55.5million) and TRIMTECH Therapeutics (£25m) were the highlights in 2025’s opening quarter for the East of England, a new KPMG study reports. The new data reveals that a …